share_log

Redhill Biopharma | EFFECT: Others

SEC announcement ·  Feb 16 19:06
Summary by Futu AI
RedHill Biopharma Ltd., a company listed on the United States Securities and Exchange Commission (SEC), has achieved a significant milestone with the Notice of Effectiveness issued by the SEC. The notice, which became effective on February 15, 2024, at 4:30 P.M., pertains to the Form F-1 filed by the company. This form is typically used by foreign issuers to register securities for offering in the U.S. market. The effectiveness of this form indicates that RedHill Biopharma has met the necessary regulatory requirements to proceed with its securities offering.
RedHill Biopharma Ltd., a company listed on the United States Securities and Exchange Commission (SEC), has achieved a significant milestone with the Notice of Effectiveness issued by the SEC. The notice, which became effective on February 15, 2024, at 4:30 P.M., pertains to the Form F-1 filed by the company. This form is typically used by foreign issuers to register securities for offering in the U.S. market. The effectiveness of this form indicates that RedHill Biopharma has met the necessary regulatory requirements to proceed with its securities offering.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.